Hasil Pencarian - Rupert McShane
- Menampilkan 1 - 12 hasil dari 12
-
1
Guidelines for ketamine use in clinical psychiatry practice oleh Luke A. Jelen, Rupert McShane, Allan H. Young
Diterbitkan 2024-05-01Dapatkan teks lengkap
Artikel -
2
Long-Term Conditions Questionnaire (LTCQ): a new tool for evaluation of integrated people-centred services in the context of multi-morbidity and complex care needs oleh Caroline Potter, Michele Peters, Maureen Cundell, Rupert McShane, Ray Fitzpatrick
Diterbitkan 2019-08-01Dapatkan teks lengkap
Artikel -
3
-
4
-
5
-
6
-
7
Preliminary Evaluation of a Web-Based International Journal Club for Ketamine in Psychiatric Disorders: Cross-Sectional Survey Study oleh Jacek R Lindner, Ashkan Ebrahimi, Julian F Kochanowicz, Justyna Szczupak, Timothy Paris, Ahmed Abdelsamie, Sagar V Parikh, Rupert McShane, Sara Costi
Diterbitkan 2023-11-01Dapatkan teks lengkap
Artikel -
8
A randomised, blinded, placebo-controlled trial in dementia patients continuing or stopping neuroleptics (the DART-AD trial). oleh Clive Ballard, Marisa Margallo Lana, Megan Theodoulou, Simon Douglas, Rupert McShane, Robin Jacoby, Katja Kossakowski, Ly-Mee Yu, Edmund Juszczak, Investigators DART AD
Diterbitkan 2008-04-01Dapatkan teks lengkap
Artikel -
9
Estimating EQ-5D utilities based on the Short-Form Long Term Conditions Questionnaire (LTCQ-8) oleh Apostolos Tsiachristas, Caroline M. Potter, Stephen Rocks, Michele Peters, Maureen Cundell, Rupert McShane, Laurie Batchelder, Diane Fox, Julien E. Forder, Karen Jones, Felicity Waite, Daniel Freeman, Ray Fitzpatrick
Diterbitkan 2020-08-01Dapatkan teks lengkap
Artikel -
10
Ketamine: stimulating antidepressant treatment? oleh Gin S. Malhi, Yulisha Byrow, Frederick Cassidy, Andrea Cipriani, Koen Demyttenaere, Mark A. Frye, Michael Gitlin, Sidney H. Kennedy, Terence A. Ketter, Raymond W. Lam, Rupert McShane, Alex J. Mitchell, Michael J. Ostacher, Sakina J. Rizvi, Michael E. Thase, Mauricio Tohen
Diterbitkan 2016-05-01Dapatkan teks lengkap
Artikel -
11
Minocycline 200 mg or 400 mg versus placebo for mild Alzheimer’s disease: the MADE Phase II, three-arm RCT oleh Robert Howard, Olga Zubko, Richard Gray, Rosie Bradley, Emma Harper, Linda Kelly, Lynn Pank, John O’Brien, Chris Fox, Naji Tabet, Gill Livingston, Peter Bentham, Rupert McShane, Alistair Burns, Craig Ritchie, Suzanne Reeves, Simon Lovestone, Clive Ballard, Wendy Noble, Gordon Wilcock, Ramin Nilforooshan
Diterbitkan 2020-04-01Dapatkan teks lengkap
Artikel -
12
An Investigation of Levetiracetam in Alzheimer’s Disease (ILiAD): a double-blind, placebo-controlled, randomised crossover proof of concept study oleh Arjune Sen, Mary Akinola, Xin You Tai, Mkael Symmonds, Gabriel Davis Jones, Sergio Mura, Joanne Galloway, Angela Hallam, Jane Y. C. Chan, Ivan Koychev, Chris Butler, John Geddes, Rohan Van Der Putt, Sian Thompson, Sanjay G. Manohar, Eleni Frangou, Sharon Love, Rupert McShane, Masud Husain
Diterbitkan 2021-07-01Dapatkan teks lengkap
Artikel